Entrar/Registro  
HOME SPANISH
 
Acta Pediátrica de México
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Acta Pediátrica de México >Year 2013, Issue 3


Gómez-Hernández FA, Sampieri A, Carmona-Aparicio L
Classification of biomarkers in central nervous system diseases
Acta Pediatr Mex 2013; 34 (3)

Language: Español
References: 9
Page: 171-172
PDF: 152.76 Kb.


Full text




Text Extraction

No abstract.


Key words: No keywords


REFERENCIAS

  1. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006;113(19):2335-62.

  2. Routh JI, Bannow RE, Fincham RW, Stoll JL. Excretion of L-dopa and its metabolites in urine of Parkinson’s disease patients receiving L-dopa therapy. Clin Chem. 1971;17(9):867- 71.

  3. Molenaar WM, Jansson DS, Gould VE, Rorke LB, Franke WW, Lee VM, Packer RJ, Trojanowski JQ. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest. 1989;61(6):635-43.

  4. Hartley SG, Goodman HO, Shihabi Z. Urinary excretion of taurine in epilepsy. Neurochem Res. 1989;14(2):149-52.

  5. Carmona-Aparicio L, Peña F, Borsodi A, Rocha L. Effects of nociceptin on the spread and seizure activity in the rat amygdala kindling model: their correlations with 3H-leucyl-nociceptin binding. Epilepsy Res. 2007;77(2-3):75-84.

  6. Carmona Aparicio L, Candeletti S, Binaschi A, Mazzuferi M, Mantovani S, Di Benedetto M, Landuzzi D, Lopetuso G, Romualdi P, Simonato M. Kainate seizures increase Nociceptin/ Orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study. J Neurochem. 2004;91(1):30-7.

  7. DeKosky ST, Marek K. Looking backward to move forward: early detection of neurodegenerative disorders. Science. 2003;302(5646):830-4.

  8. Berg D. Biomarkers for the early detection of Parkinson’s and Alzheimer’s disease. Neurodegener Dis. 2008;5(3-4):133-6.

  9. Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis. 2009;35(2):65-76.






>Journals >Acta Pediátrica de México >Year 2013, Issue 3
 

· Journal Index 
· Links 






       
Copyright 2019